EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Drug-Coated Balloon Treatment for De Novo Coronary Lesions: Current Status and Future Perspectives

Ae-Young Her iD, Eun-Seok Shin iD

Korean Circulation Journal · 2024 · 54 (9) · 519

DOI: 10.4070/kcj.2024.0148 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Korean Circulation Journal, 2024. Verfasst von Ae-Young Her und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Kangwon National University School of Medic…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The outstanding development in contemporary medicine, highlighted by percutaneous coronary intervention (PCI), was achieved through the adoption of drug-eluting stents (DESs). Although DES is the established therapy for patients undergoing PCI for de novo coronary artery disease (CAD), their drawbacks include restenosis, stent thrombosis, and the requirement for dual antiplatelet therapy (DAPT) with an uncertain duration regarding its optimality. Drug-coated balloon (DCB) treatment leaves nothing behind on the vessel wall, providing the benefit of avoiding stent thrombosis and not necessitating obligatory extended DAPT. After optimizing coronary blood flow, DCB treatment delivers an anti-proliferative drug directly coated on a balloon. Although more evidence is needed for the application of DCB treatment in de novo coronary lesions, recent studies suggest the safety and effectiveness of DCB treatment for diverse conditions including small and large vessel diseases, complex lesions like bifurcation lesions or diffuse or multivessel diseases, chronic total occlusion lesions, acute myocardial infarctions, patients at high risk of bleeding, and beyond. Consequently, we will review the current therapeutic choices for managing de novo CAD using DCB and assess the evidence supporting their concurrent application. Additionally, it aims to discuss future important perspectives.

Schlagwörter

Stichwörter der Autor:innen

Coronary artery diseaseDe novoDrug-coated balloonDrug-eluting stentPercutaneous coronary intervention

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.
  • Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea. sesim1989@gmail.com.

ORCID-Profile: Ae-Young Her, Eun-Seok Shin

Zitieren

APA

Her, A. Y., & Shin, E. S. (2024). Drug-Coated Balloon Treatment for De Novo Coronary Lesions: Current Status and Future Perspectives. Korean Circulation Journal, 54(9), 519. https://doi.org/10.4070/kcj.2024.0148

Vancouver

Her AY, Shin ES. Drug-Coated Balloon Treatment for De Novo Coronary Lesions: Current Status and Future Perspectives. Korean Circulation Journal. 2024;54(9):519. doi:10.4070/kcj.2024.0148

BibTeX
@article{Her2024,
  author = {Her, Ae-Young and Shin, Eun-Seok},
  title = {Drug-Coated Balloon Treatment for De Novo Coronary Lesions: Current Status and Future Perspectives},
  journal = {Korean Circulation Journal},
  year = {2024},
  volume = {54},
  number = {9},
  pages = {519},
  doi = {10.4070/kcj.2024.0148}
}
Kostenlos starten →